Literature DB >> 10881937

Induction of acute pancreatitis by cerulein in human IL-6 gene transgenic mice.

S Suzuki1, K Miyasaka, A Jimi, A Funakoshi.   

Abstract

Whether acute pancreatitis induced by cerulein was aggravated in human interleukin 6 (IL-6) transgenic mice and whether a specific anti-IL-6 receptor antibody improved pancreatitis were investigated. To induce acute pancreatitis, cerulein (50 microg/kg, seven injections) with or without 1 mg/kg lipopolysaccharides (LPS) was injected intraperitoneally every hour. In some mice, a monoclonal anti-IL-6 receptor antibody was administered before the first cerulein injection. The animals were killed 1 hour after the last injection. The pancreatic wet weight induced by cerulein alone was significantly higher in IL-6 transgenic mice compared with wild-type mice, but pretreatment with a specific anti-IL-6 receptor antibody did not reduce interstitial edema. When cerulein was administered with LPS, the pancreatic wet weight increased much more than when pancreatitis was induced by cerulein alone in both genotypes, and pretreatment with the anti-IL-6 receptor antibody decreased the pancreatic edema only in human-IL-6 transgenic mice. These results suggest that anticytokine antibodies may be effective in improving acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881937     DOI: 10.1097/00006676-200007000-00056

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  11 in total

1.  Experimental study of therapeutic efficacy of Baicalin in rats with severe acute pancreatitis.

Authors:  Xi-Ping Zhang; Ling Zhang; Jin-Xian He; Rui-Ping Zhang; Qi-Hu Cheng; Yi-Feng Zhou; Bei Lu
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

Review 2.  IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.

Authors:  B E Barton
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 3.  Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Zobeida Cruz-Monserrate; Brian M Davis; Mouad Edderkaoui; Guido Eibl; Ariel Y Epouhe; Jeremy Y Gedeon; Fred S Gorelick; Paul J Grippo; Guy E Groblewski; Sohail Z Husain; Keane K Y Lai; Stephen J Pandol; Aliye Uc; Li Wen; David C Whitcomb
Journal:  Pancreas       Date:  2019-07       Impact factor: 3.327

4.  Dendritic cells promote pancreatic viability in mice with acute pancreatitis.

Authors:  Andrea S Bedrosian; Andrew H Nguyen; Michael Hackman; Michael K Connolly; Ashim Malhotra; Junaid Ibrahim; Napoleon E Cieza-Rubio; Justin R Henning; Rocky Barilla; Adeel Rehman; H Leon Pachter; Marco V Medina-Zea; Steven M Cohen; Alan B Frey; Devrim Acehan; George Miller
Journal:  Gastroenterology       Date:  2011-07-27       Impact factor: 22.682

Review 5.  Animal models of pancreatitis: can it be translated to human pain study?

Authors:  Jing-Bo Zhao; Dong-Hua Liao; Thomas Dahl Nissen
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

Review 6.  Immune-modulating therapy in acute pancreatitis: fact or fiction.

Authors:  Karolina Akinosoglou; Charalambos Gogos
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

Review 7.  Oxidative stress and inflammatory signaling in cerulein pancreatitis.

Authors:  Ji Hoon Yu; Hyeyoung Kim
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 8.  Pathophysiological mechanisms in acute pancreatitis: Current understanding.

Authors:  Pankaj Singh; Pramod Kumar Garg
Journal:  Indian J Gastroenterol       Date:  2016-05-21

9.  Review of experimental animal models of acute pancreatitis.

Authors:  Kim Hue Su; Christine Cuthbertson; Christopher Christophi
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

10.  The adipocytokine resistin stimulates the production of proinflammatory cytokines TNF-α and IL-6 in pancreatic acinar cells via NF-κB activation.

Authors:  C Y Jiang; W Wang; J X Tang; Z R Yuan
Journal:  J Endocrinol Invest       Date:  2013-06-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.